» Articles » PMID: 31377789

Interplay of Cardiac Remodelling and Myocardial Stiffness in Hypertensive Heart Disease: a Shear Wave Imaging Study Using High-frame Rate Echocardiography

Overview
Date 2019 Aug 5
PMID 31377789
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To determine myocardial stiffness by means of measuring the velocity of naturally occurring myocardial shear waves (SWs) at mitral valve closure (MVC) and investigate their changes with myocardial remodelling in patients with hypertensive heart disease.

Methods And Results: Thirty-three treated arterial hypertension (HT) patients with hypertrophic left ventricular (LV) remodelling (59 ± 14 years, 55% male) and 26 aged matched healthy controls (55±15 years, 77% male) were included. HT patients were further divided into a concentric remodelling (HT1) group (13 patients) and a concentric hypertrophy (HT2) group (20 patients). LV parasternal long-axis views were acquired with an experimental ultrasound scanner at 1266 ± 317 frames per seconds. The SW velocity induced by MVC was measured from myocardial acceleration maps. SW velocities differed significantly between HT patients and controls (5.83 ± 1.20 m/s vs. 4.04 ± 0.96 m/s; P < 0.001). In addition, the HT2 group had the highest SW velocities (P < 0.001), whereas values between controls and the HT1 group were comparable (P = 0.075). Significant positive correlations were found between SW velocity and LV remodelling (interventricular septum thickness: r = 0.786, P < 0.001; LV mass index: r = 0.761, P < 0.001). SW velocity normalized for wall stress indicated that myocardial stiffness in the HT2 group was twice as high as in controls (P < 0.001), whereas values of the HT1 group overlapped with the controls (P = 1.00).

Conclusions: SW velocity as measure of myocardial stiffness is higher in HT patients compared with healthy controls, particularly in advanced hypertensive heart disease. Patients with concentric remodelling have still normal myocardial properties whereas patients with concentric hypertrophy show significant stiffening.

Citing Articles

Personalized biomechanical insights in atrial fibrillation: opportunities & challenges.

Telle A, Bargellini C, Chahine Y, Del Alamo J, Akoum N, Boyle P Expert Rev Cardiovasc Ther. 2023; 21(11):817-837.

PMID: 37878350 PMC: 10841537. DOI: 10.1080/14779072.2023.2273896.


Antagonism of contractile forces in left ventricular hypertrophy: a diagnostic challenge for better pathophysiological and clinical understanding.

Lunkenheimer P, Hagendorff A, Lunkenheimer J, Gulker H, Niederer P Open Heart. 2023; 10(2).

PMID: 37827810 PMC: 10582970. DOI: 10.1136/openhrt-2023-002351.


[Echocardiography with high frame rates in the clinical practice : Principles, applications and perspectives].

Petrescu A, Voigt J Herz. 2023; 48(5):339-351.

PMID: 37530782 DOI: 10.1007/s00059-023-05199-x.


Special Issue: Hypertensive Heart Disease-From Pathophysiology to Therapeutical Challenges.

Vischer A, Burkard T J Clin Med. 2022; 11(16).

PMID: 36012879 PMC: 9410174. DOI: 10.3390/jcm11164640.


Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts.

Bishop S, Zhang J, Ye L Biology (Basel). 2022; 11(6).

PMID: 35741401 PMC: 9220194. DOI: 10.3390/biology11060880.